Triggering the succinate receptor GPR91 enhances pressure overload-induced right ventricular hypertrophy

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5415-5428

  Yang, Lei ^a   Yu, Di ^a   Fan, Huan Huan ^b   Feng, Yu ^a   Hu, Liang ^a   Zhang, Wei Yan ^a   Zhou, Kai ^a   Mo, Xu Ming ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Pi3K Akt; Right ventricular hypertrophy; Succinate G protein receptor 91

Indexed keywords

ATRIAL NATRIURETIC FACTOR; G PROTEIN COUPLED RECEPTOR; GPR91 PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SUCCINIC ACID;

AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HYPERTROPHY, RIGHT VENTRICULAR; MALE; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PULMONARY HYPERTENSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUCCINIC ACID; TIME FACTORS; TRANSFECTION;

EID: 84911465693     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Azakie A, Fineman J, He Y. Differential responses of the right ventricle to abnormal loading conditions in vivo: possible pathophysiologic mechanisms. J Thorac Cardiovasc Surg 2013; 145: 1335-1344.
2. Meng L, Liu X, Zheng Z, Li J, Meng J, Wei Y, Hu S. Original rat model of high kinetic unilateral pulmonary hypertension surgically induced by combined surgery. J Thorac Cardiovasc Surg 2013; 146: 1220-1226.
3. Nguyen R, Mir TS, Kluwe L, Jett K, Kentsch M, Mueller G, Kehrer-Sawatzki H, Friedman J, Mautner VF. Cardiac characterization of 16 patients with large NF1 gene deletions. Clin Genet 2013; 84: 344-349.
4. Farmer DG, Ewart MA, Mair KM, Kennedy S. Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic ypoxia in the mouse. Pulm Pharmacol Ther, 2014, [Epub ahead of print]
5. Angeli E, Pace Napoleone C, Turci S, Oppido G, Gargiulo G. Pulmonary artery banding. Multimed Man Cardiothorac Surg 2012; 2012: mms010.
6. 1Mapping Detects Pharma-cological Retardation of Diffuse Cardiac Fib-rosis in Mouse Pressure-overload Hyper-trophy. Circ Cardiovasc Imaging 2014; 7: 240-9.
7. Dunlop K, Gosal K, Kantores C, Ivanovska J, Dhaliwal R, Desjardins JF, Connelly KA, Jain A, McNamara PJ, Jankov RP. Therapeutic hypercapnia prevents inhaled nitric oxide-induced right ventricular systolic dysfunction in juvenile rats. Free Radic Biol Med 2014; 69: 35-49.
8. Bove T, Vandekerckhove K, Bouchez S, Wouters P, Somers P, Van Nooten G. Role of myocardial hypertrophy on acute and chronic right ventricular performance in relation to chronic volume overload in a porcine model: Relevance for the surgical management of tetralogy of Fallot. J Thorac Cardiovasc Surg 2014; 147: 1956-65.
9. J Sánchez-Lázaro I, Almenar Bonet L, Igual Muñoz B, Rueda-Soriano J, Martínez-Dolz L, Zorio-Grima E, Angel Arnau-Vives M, Salvador-Sanz A. Phenotypic patterns of right ventricular dysfunction: analysis by cardiac magnetic imaging. Heart Int 2013; 8: e3.
10. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, Connolly DT, Behan DP. The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol 2009; 85: 837-843.
11. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity 2013; 38: 633-643.
12. Mills E, O'Neill LA. Succinate: a metabolic signal in inflammation. Trends Cell Biol 2014; 24: 313-20.
13. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O'Neill LA. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013; 496: 238-242.
14. Dias CA, Assad RS, Caneo LF, Abduch MC, Aiello VD, Dias AR, Marcial MB, Oliveira SA. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2002; 124: 999-1006.
15. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004; 429: 188-193.
16. Aguiar CJ, Andrade VL, Gomes ER, Alves MN, Ladeira MS, Pinheiro AC, Gomes DA, Almeida AP, Goes AM, Resende RR, Guatimosim S, Leite MF. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 2010; 47: 37-46.
17. Chen YL, Su MC, Liu WH, Wang CC, Lin MC, Chen MC. Influence and Predicting Variables of Obstructive Sleep Apnea on Cardiac Function and Remodeling in Patients without Congestive Heart Failure. J Clin Sleep Med 2014; 10: 57-64.
18. Novoyatleva T, Janssen W, Wietelmann A, Schermuly RT, Engel FB. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy. Cytokine 2013; 64: 43-45.
19. Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, Berger RM. A cornerstone of heart failure treatment is not effective in experimental right ventricular failure. Int J Cardiol 2013; 169: 183-189.
20. Stastna M, Van Eyk JE. Optimized method for identification of the proteomes secreted by cardiac cells. Methods Mol Biol 2013; 1005: 225-235.
21. Picatoste B, Ramirez E, Caro-Vadillo A, Iborra C, Ares-Carrasco S, Egido J, Tunon J, Lorenzo O. Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms. PLoS One 2013; 8: e78330.
22. Chiarini A, Micucci M, Malaguti M, Budriesi R, Ioan P, Lenzi M, Fimognari C, Gallina Toschi T, Comandini P, Hrelia S. Sweet chestnut (Castanea sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage. Oxid Med Cell Longev 2013; 2013: 471790.
23. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honore JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beauséjour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008; 14: 1067-1076.
24. Kohler D, Arnold R, Loukanov T, Gorenflo M. Right Ventricular Failure and Pathobiology in Patients with Congenital Heart Disease-Implications for Long-Term Follow-Up. Front Pediatr 2013; 1: 37.
25. McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O. Treatment goals of pulmonary hypertension. J Am Coll Cardiol 2013; 62 Suppl: D73-81.
26. Beghetti M, Tissot C. Pulmonary arterial hypertension and congenital heart disease: targeted therapies and operability. J Thorac Cardiovasc Surg 2009; 138: 785-786.
27. Mohr FW, Seeburger J, Misfeld M. Keynote Lecture-Transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair. Ann Cardio-thorac Surg 2013; 2: 729-732.
28. Joassard OR, Amirouche A, Gallot YS, Des-georges MM, Castells J, Durieux AC, Berthon P, Freyssenet DG. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle. Int J Biochem Cell Biol 2013; 45: 2444-2455.
29. Anderson RH, Spicer DE, Giroud JM, Mohun TJ. Tetralogy of Fallot: nosological, morphological, and morphogenetic considerations. Cardiol Young 2013; 23: 857-865.
30. van de Veerdonk MC, Dusoswa SA, Tim Marcus J, Bogaard HJ, Spruijt O, Kind T, Westerhof N, Vonk-Noordegraaf A. The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload. Int J Cardiovasc Imaging 2014; 30: 357-65.
31. McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes 2014; 7: 13-4.
32. Kapur NK, Paruchuri V, Aronovitz MJ, Qiao X, Mackey EE, Daly GH, Ughreja K, Levine J, Blanton R, Hill NS, Karas RH. Biventricular remodeling in murine models of right ventricular pressure overload. PLoS One 2013; 8: e70802.
33. Arsenault M, Zendaoui A, Roussel E, Drolet MC, Dhahri W, Grenier A, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J. Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation. Circ Heart Fail 2013; 6: 1021-1028.
34. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol 2011; 45: 1239-1247.
35. Rothermund L, Lorenz M, Schnieber A, Eberson J, Bauhaus I, Bernhard Haug M, Schulz A, Keller F, Vetter R, Kreutz R. Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition. Am J Hypertens 2011; 4: 474-481.
36. Sundstrom L, Greasley PJ, Engberg S, Wallander M, Ryberg E. Succinate receptor GPR91, a Gα(i) coupled receptor that increases intracellular calcium concentrations through PLCβ. FEBS Lett 2013; 587: 2399-2404.
37. Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Fail 2013; 6: 1039-1048.
38. Gartner F, Seidel T, Schulz U, Gummert J, Milting H. Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation. J Biol Chem 2013; 288: 32138-32148.
39. Sheth H, Gorey C, Roush N, Smallman S, Collantes E, Santoro M, Olson B, Fitzgerald L, Lee PH, Shen XJ. A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists. Curr Chem Genomics Transl Med 2013; 7: 1-8.
40. Andrews SP, Brown GA, Christopher JA. Structure-Based and Fragment-Based GPCR Drug Discovery. Med Chem 2014; 9: 256-75.
41. Zhan X, Wang J, Liu Y, Peng Y, Tan W. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Mol Cancer 2014; 13: 4.
42. Heinke J, Juschkat M, Charlet A, Mnich L, Helbing T, Bode C, Patterson C, Moser M. Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation. J Cell Sci 2013; 126: 3082-3094.
43. Banerjee P, Bandyopadhyay A. Cytosolic dynamics of annexin A6 triggers feedback regulation of hypertrophy via atrial natriuretic peptide in cardiomyocytes. J Biol Chem 2014; 289: 5371-85.
44. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 2013; 113: 603-616.
45. Lee H, Yoo YS, Lee D, Song EJ. Cholesterol induces cardiac hypertrophy by activating the AKT pathway. J Steroid Biochem Mol Biol 2013; 138: 307-313.
46. Montano MM, Desjardins CL, Doughman YQ, Hsieh YH, Hu Y, Bensinger HM, Wang C, Stelzer JE, Dick TE, Hoit BD, Chandler MP, Yu X, Watanabe M. Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse. Cardiovasc Res 2013; 99: 74-82.
47. Vazquez-Medina JP, Popovich I, Thorwald MA, Viscarra JA, Rodriguez R, Sonanez-Organis JG, Lam L, Peti-Peterdi J, Nakano D, Nishiyama A, Ortiz RM. Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats. Am J Physiol Heart Circ Physiol 2013; 305: H599-607.
48. Wang HX, Yang H, Han QY, Li N, Jiang X, Tian C, Du J, Li HH. NADPH oxidases mediate a cellular "memory" of angiotensin II stress in hypertensive cardiac hypertrophy. Free Radic Biol Med 2013; 65: 897-907.
49. Cannavo A, Liccardo D, Koch WJ. Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy. Front Physiol 2013; 4: 264.